MDMA Therapy

Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds
Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
Senators Press FDA To Approve MDMA As PTSD Treatment, Stressing US Vets' Suicide Rates As Aug 11 Decision Looms
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates

MDMA Therapy Recent News

Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.) 
Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials
Cybin One Steps Away From Complete Dosing
How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
Licensed psychedelic drugs producer Optimi Health Corp. (OTCQX: OPTHF) submitted a Health Canada clinical trial application (CTA) for a Phase 1 study that will assess the safety of combining its natural psilocybin standardized extract with its proprietary MDMA drug candidate in healthy therapists.
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Ketamine products manufacturer PharmaTher Holdings Ltd. (OTCQB: PHRRF) had lots happening this past week. Here are the company's top three news items.
Three More State-Level Psychedelic Bills In The Works: MO, MA And NY
An increasing number of state lawmakers are aiming to introduce psychedelic legalization bills to their respective House of Representatives and Senates. Let’s take a look at some of the latest proposals.
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
Health Canada Oks Clinical-Grade MDMA Export To UK Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its manufacturing partners received a Health Canada export permit for no less than 300 grams of proprietary MDMA LaNeo.
Two Psychedelics Companies Will Study Effects Of Natural Psilocybin And MDMA In Healthy Volunteers
Health Canada receives applications concerning clinical trials on a regular basis.  This time, the licensed producer of natural EU-GMP psilocybin and MDMA Optimi Health Corp.
Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead
Optimi Health Corp.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved